SI-BONE, Inc.
- Jurisdiction
United States - LEI
549300J8JGYVJJHV9C31 - ISIN
US8257041090 (SIBN )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. Read full profile
Fundamentals
- Net revenue
€150.63M - Gross margin
79.2% - EBIT
-€26.17M - EBIT margin
-17.4% - Net income
-€22.65M - Net margin
-15.0%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| FRANCIS LAURA | Chief Executive Officer |
|
|
|
|
| Maheshwari Anshul | Chief Financial Officer |
|
|
|
|
| PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr |
|
|
|
|
| RECUPERO ANTHONY J | President, Commercial Ops |
|
|
|
|
| Freund John Gordon | N/A |
|
|
|
|
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Buy |
Earnings Calls
Latest earnings call: August 5, 2025 (Q2 2025)